CSL Limited
CSL
Rangering i aksjer
#367
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Aksjekurs
$136.26
Markedsverdi
$65.39B
Endring (1 dag)
-0.61%
Endring (1 år)
-4.06%
Land
AU
Handel CSL Limited (CSL)
Kategori
Healthcare
Driftsmargin for CSL Limited (CSL)
Driftsmargin per October 2026 TTM: 25.57%
Ifølge CSL Limited sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 25.57%. Ved slutten av 2024 hadde selskapet en driftsmargin på 18.82%.
Historikk for driftsmargin for CSL Limited fra 2000 til 2026
Driftsmargin ved slutten av hvert år
| År | Driftsmargin | Endre |
|---|---|---|
| 2026 (TTM) | 25.57% | 33.32% |
| 2025 | 19.18% | 1.91% |
| 2024 | 18.82% | 17.92% |
| 2023 | 15.96% | -27.68% |
| 2022 | 22.07% | -11.97% |
| 2021 | 25.07% | 4.98% |
| 2020 | 23.88% | -17.28% |
| 2019 | 28.87% | 22.59% |
| 2018 | 23.55% | 27.09% |
| 2017 | 18.53% | 11.02% |
| 2016 | 16.69% | -35.98% |
| 2015 | 26.07% | 2.64% |
| 2014 | 25.40% | 10.82% |
| 2013 | 22.92% | 13.69% |
| 2012 | 20.16% | -7.48% |
| 2011 | 21.79% | -9.25% |
| 2010 | 24.01% | 30.70% |
| 2009 | 18.37% | 6.55% |
| 2008 | 17.24% | 0.23% |
| 2007 | 17.20% | 1,146.38% |
| 2006 | 1.38% | -84.17% |
| 2005 | 8.72% | 448.43% |
| 2004 | 1.59% | -63.95% |
| 2003 | 4.41% | -49.60% |
| 2002 | 8.75% | -193.38% |
| 2001 | -9.37% | 0.00% |
| 2000 | 0.00% | 0.00% |
Driftsmargin for lignende selskaper eller konkurrenter
| Selskap | Driftsmargin | Forskjell i driftsmargin | Land |
|---|---|---|---|
| 38.59% | -98.49% |
US
|
|
| -149.01% | -105.83% |
US
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -98.87% |
NL
|
|
| 31.23% | -98.78% |
BE
|
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.